ATE532071T1 - Verfahren zur verminderung von eiweiss in proben - Google Patents

Verfahren zur verminderung von eiweiss in proben

Info

Publication number
ATE532071T1
ATE532071T1 AT04104644T AT04104644T ATE532071T1 AT E532071 T1 ATE532071 T1 AT E532071T1 AT 04104644 T AT04104644 T AT 04104644T AT 04104644 T AT04104644 T AT 04104644T AT E532071 T1 ATE532071 T1 AT E532071T1
Authority
AT
Austria
Prior art keywords
methods
samples
ligand
albumin
reducing protein
Prior art date
Application number
AT04104644T
Other languages
English (en)
Inventor
William Galbraith
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE532071T1 publication Critical patent/ATE532071T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT04104644T 2003-09-25 2004-09-24 Verfahren zur verminderung von eiweiss in proben ATE532071T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50663403P 2003-09-25 2003-09-25
US50657903P 2003-09-26 2003-09-26
US53137703P 2003-12-19 2003-12-19
US10/804,592 US20050037331A1 (en) 2003-08-13 2004-03-19 Apparatuses and methods for reducing albumin in samples
US10/922,560 US7790475B2 (en) 2003-09-25 2004-08-19 Apparatuses and methods for reducing albumin in samples

Publications (1)

Publication Number Publication Date
ATE532071T1 true ATE532071T1 (de) 2011-11-15

Family

ID=34397187

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04104644T ATE532071T1 (de) 2003-09-25 2004-09-24 Verfahren zur verminderung von eiweiss in proben

Country Status (4)

Country Link
US (2) US20050037331A1 (de)
EP (1) EP1519195B1 (de)
JP (1) JP4803986B2 (de)
AT (1) ATE532071T1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060094865A1 (en) * 2004-10-29 2006-05-04 Kapur Terri A Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions
GB0621452D0 (en) * 2006-10-27 2006-12-06 Ucl Business Plc Therapy for liver disease
MX345403B (es) 2009-05-13 2017-01-30 Sio2 Medical Products Inc Revestimiento por pecvd utilizando un precursor organosilícico.
US9458536B2 (en) 2009-07-02 2016-10-04 Sio2 Medical Products, Inc. PECVD coating methods for capped syringes, cartridges and other articles
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
US9272095B2 (en) 2011-04-01 2016-03-01 Sio2 Medical Products, Inc. Vessels, contact surfaces, and coating and inspection apparatus and methods
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
EP2776603B1 (de) 2011-11-11 2019-03-06 SiO2 Medical Products, Inc. Passivierungs-, ph-schutz- oder schmierbeschichtung für arzneimittelverpackung, beschichtungsverfahren und vorrichtung
CA2887352A1 (en) 2012-05-09 2013-11-14 Sio2 Medical Products, Inc. Saccharide protective coating for pharmaceutical package
EP2914762B1 (de) 2012-11-01 2020-05-13 SiO2 Medical Products, Inc. Verfahren zur inspektion einer beschichtung
US9903782B2 (en) 2012-11-16 2018-02-27 Sio2 Medical Products, Inc. Method and apparatus for detecting rapid barrier coating integrity characteristics
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
WO2014085348A2 (en) 2012-11-30 2014-06-05 Sio2 Medical Products, Inc. Controlling the uniformity of pecvd deposition on medical syringes, cartridges, and the like
US9662450B2 (en) 2013-03-01 2017-05-30 Sio2 Medical Products, Inc. Plasma or CVD pre-treatment for lubricated pharmaceutical package, coating process and apparatus
KR102472240B1 (ko) 2013-03-11 2022-11-30 에스아이오2 메디컬 프로덕츠, 인크. 코팅된 패키징
US9937099B2 (en) 2013-03-11 2018-04-10 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging with low oxygen transmission rate
WO2014144926A1 (en) 2013-03-15 2014-09-18 Sio2 Medical Products, Inc. Coating method
KR20150005226A (ko) * 2013-07-05 2015-01-14 한국전자통신연구원 혈액 전처리 장치 및 방법
US11066745B2 (en) 2014-03-28 2021-07-20 Sio2 Medical Products, Inc. Antistatic coatings for plastic vessels
US11077233B2 (en) 2015-08-18 2021-08-03 Sio2 Medical Products, Inc. Pharmaceutical and other packaging with low oxygen transmission rate
WO2024097706A1 (en) * 2022-11-02 2024-05-10 University Of Washington System for removing protein bound uremic toxins during hemodialysis

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061466A (en) * 1974-10-16 1977-12-06 Ingvar Gosta Holger Sjoholm Biologically active composition and the use thereof
US4093612A (en) * 1975-08-04 1978-06-06 Research Corporation Selective removal of albumin from blood fluids and compositions therefore
CA2068220A1 (en) * 1989-11-08 1991-05-09 Samuel Nochumson Combined centrifuge tube and porous selection means for separation and recovery of biological materials
JPH0486554A (ja) 1990-07-30 1992-03-19 Tosoh Corp 糖化アルブミンの分析方法
GB9024771D0 (en) * 1990-11-14 1991-01-02 Axis Research Assay
DE4309410A1 (de) * 1993-03-19 1995-02-16 Stange Jan Material, Verfahren und Einrichtung zur selektiven Trennung frei gelöster und stoffgebundener Stoffe aus flüssigen Stoffgemischen sowie Verfahren zur Herstellung des Materials
CA2127605A1 (en) * 1993-12-23 1995-06-24 Peter J. Degen Affinity separation method
US5643721A (en) * 1994-02-09 1997-07-01 Abbott Laboratories Bioreagent immobilization medium
US5919626A (en) * 1997-06-06 1999-07-06 Orchid Bio Computer, Inc. Attachment of unmodified nucleic acids to silanized solid phase surfaces
SE9802213D0 (sv) * 1998-06-18 1998-06-18 Amersham Pharm Biotech Ab A method for the removal/purification of serum albumins and means for use in the method
US6680176B2 (en) * 1999-05-17 2004-01-20 The United States Of America, As Represented By The Department Of Health And Human Services Identification of candidate ligands which modulate antigen presenting cells
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
US7691645B2 (en) * 2001-01-09 2010-04-06 Agilent Technologies, Inc. Immunosubtraction method
US20030032000A1 (en) * 2001-08-13 2003-02-13 Signature Bioscience Inc. Method for analyzing cellular events
AU2002361623A1 (en) * 2001-11-09 2003-05-19 Kinetic Biosystems Inc. Methods and compositions for chromatography
US20050042772A1 (en) * 2003-02-07 2005-02-24 Beyond Genomics Removal of proteins from a sample

Also Published As

Publication number Publication date
US20050074870A1 (en) 2005-04-07
EP1519195B1 (de) 2011-11-02
JP2005114723A (ja) 2005-04-28
EP1519195A2 (de) 2005-03-30
US7790475B2 (en) 2010-09-07
US20050037331A1 (en) 2005-02-17
EP1519195A3 (de) 2005-06-01
JP4803986B2 (ja) 2011-10-26

Similar Documents

Publication Publication Date Title
ATE532071T1 (de) Verfahren zur verminderung von eiweiss in proben
ATE433999T1 (de) Verfahren zur aufreinigung von albumin-konjugaten
ATE447180T1 (de) Verfahren zur vorbehandlung von proben sowie immuntestverfahren unter dessen verwendung
DE60325482D1 (de) Verfahren zur charakterisierung von biomolekülen mittels resultat-gesteuerter strategie
ATE375003T1 (de) Apparat und methode zur abtrennung einer halbleiterscheibe von einem träger
DE69132098D1 (de) Verfahren zur amplifikation von nukleinsäuren
ATE492813T1 (de) Verfahren zur isolierung von analyten aus einer probe
ATE540319T1 (de) Verfahren für die bestimmung von fk506
DE602004026912D1 (de) Formulierungen und verfahren zum denaturieren von proteinen
WO2004063704A3 (en) Vitamin d assay
DE60104810D1 (de) Zellfreies Verfahren zur Herstellung von posttranslational veränderten Proteinen
DE602005012405D1 (de) Verfahren zur chiralen inversion von (s)-(+)- und (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepin-5-carbonsäureamid und optisch angereicherten mischungen davon
DE602005019156D1 (de) Verfahren zur auswertung von ribonukleotidsequenzen
DE602005023363D1 (de) Vorrichtung und Verfahren zur Authentifizierung von Blutgefässen
ATE310718T1 (de) Verfahren zur herstellung von (meth)acrylsäureanhydrid
ATE348111T1 (de) Verfahren zur herstellung von humanem serumalbumin unter verwendung eines aufwarmschrittes
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE416619T1 (de) Verfahren zur dearomatisierung von molkeprotein
DE60226125D1 (de) Verfahren zur quantifizierung von glykiertem protein
ATE446378T1 (de) Verfahren zur analyse von komponenten biologischer proben
ATE246692T1 (de) Verfahren zur reinigung von phosphatidylserin
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE60332111D1 (de) Transgene huftiere, die zur produktion von menschlichen antikörpern fähig sind
AU2003260392A1 (en) Method for enriching a prokaryotic dna
ATE427490T1 (de) Verfahren zur probenvorbehandlung sowie immunologisches testverfahren unter verwendung davon